REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmalogica S.A (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Farmalogica S.A Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Farmalogica S.A is based in Colombia, with the head office in Bogota D.C.. It operates in the Pharmaceutical Preparation Manufacturing industry. It was established on May 18, 1999. It currently has a total number of 175 (2024) employees. From the latest financial highlights, Farmalogica S.A reported a net sales revenue increase of 35.3% in 2023. A growth of 9.97% was recorded in its total assets.

Headquarters
Cr 43A # 20 B - 07
Bogota D.C.; Bogota D.C; Postal Code: 0607

Contact Details: Purchase the Farmalogica S.A report to view the information.

Basic Information
Total Employees:
Purchase the Farmalogica S.A report to view the information.
Outstanding Shares:
Purchase the Farmalogica S.A report to view the information.
Registered Capital:
Purchase the Farmalogica S.A report to view the information.
Incorporation Date:
May 18, 1999
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Farmalogica S.A report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
35.3%
Total operating revenue
53.32%
Operating profit (EBIT)
280.22%
EBITDA
220.17%
Net Profit (Loss) for the Period
N/A
Total assets
9.97%
Total equity
59.39%
Operating Profit Margin (ROS)
15.54%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-17.35%
Quick Ratio
0.24%
Cash Ratio
0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?